MedTrace Logo

Predictive OCTA Biomarkers After Endoscopic Endonasal Pituitary Surgery

NCT04840771 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8

Last updated 2021-05-06

No results posted yet for this study

Summary

This study evaluates the structural parameters, by spectral domain optical coherence tomography (OCT), retinal vessel density, using OCT angiography, and visual acuity in patients that received endoscopic endonasal approach for the removal of an intra-suprasellar pituitary adenoma compressing the optic nerve.

Conditions

  • Pituitary Adenoma

Interventions

PROCEDURE

Endoscopic Endonasal Pituitary Surgery

Surgical treatment consisted of an endoscopic endonasal approach using a rigid 0-degree endoscope, 18 cm in length and 4 mm in diameter.

Sponsors & Collaborators

  • Federico II University

    lead OTHER

Principal Investigators

  • Gilda Cennamo · Federico II University

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2020-07-30
Completion
2020-07-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04840771 on ClinicalTrials.gov